RUA Life Sciences Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0033360586
GBP
0.12
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kromek Group Plc
Cambridge Nutritional Sciences Plc
Surgical Innovations Group Plc
Polarean Imaging Plc
NetScientific Plc
Inspiration Healthcare Group Plc
RUA Life Sciences Plc
MyHealthChecked Plc
Abingdon Health Plc
Proteome Sciences Plc
Genedrive Plc
Why is RUA Life Sciences Plc ?
1
Flat results in Mar 25
  • NET PROFIT(Q) At GBP -0.63 MM has Fallen at -46.51%
  • RAW MATERIAL COST(Y) Grown by 5.92% (YoY)
2
With ROE of 0.01%, it has a expensive valuation with a 0.98 Price to Book Value
  • Over the past year, while the stock has generated a return of 11.11%, its profits have risen by 100% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is RUA Life Sciences Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
RUA Life Sciences Plc
11.11%
0.18
38.05%
FTSE 100
15.94%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
35.81%
EBIT Growth (5y)
-0.61%
EBIT to Interest (avg)
-1.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.33
Tax Ratio
1.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.00%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
0.98
EV to EBIT
-3.98
EV to EBITDA
-3.98
EV to Capital Employed
0.96
EV to Sales
0.97
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
-23.89%
ROE (Latest)
0.01%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at GBP -1.57 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 4.03%

-6What is not working for the Company
NET PROFIT(Q)

At GBP -0.63 MM has Fallen at -46.51%

RAW MATERIAL COST(Y)

Grown by 5.92% (YoY

Here's what is working for RUA Life Sciences Plc
Debtors Turnover Ratio
Highest at 4.03% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Cash Flow
Highest at GBP -1.57 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Here's what is not working for RUA Life Sciences Plc
Net Profit
At GBP -0.63 MM has Fallen at -46.51%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (GBP MM)

Raw Material Cost
Grown by 5.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales